---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-044741"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2026-04-16T23:59:59+00:00"
generated_at: "2026-05-15T05:48:48.775011+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Hoth Therapeutics resumes ATM equity offering under existing H.C. Wainwright agreement

## Summary
- On April 16, 2026, Hoth filed a new prospectus supplement to resume sales of common stock under its ATM agreement with H.C. Wainwright.
- The ATM offering was previously suspended on April 1, 2026, but the Sales Agreement remained in effect.
- The new prospectus supplement relates to the company's existing effective S-3 registration statement (File No. 333-291566).
- No specific terms (size, price, or expected proceeds) were disclosed in the filing.

## SEC filing metadata
- accession: 0001213900-26-044741
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2026-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/0001213900-26-044741-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/ea0286719-8k_hoth.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-044741
- JSON: https://secwatch.observer/filing/0001213900-26-044741.json
- Plain text: https://secwatch.observer/filing/0001213900-26-044741.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.